Large motor neuron involvement in Stiff-man syndrome: a qualitative and quantitative study

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Stiff-man syndrome (SMS) is a neurological disorder marked by muscle rigidity and spasms.
• Elevated antibodies against glutamic acid decarboxylase (GAD), an enzyme crucial for GABA synthesis, are found in SMS patients, suggesting an autoimmune basis.
• This proposed autoimmune mechanism targets GABAergic inhibitory interneurons, leading to motor dysfunction.

Observation:

• Post-mortem quantitative analysis of the spinal cord ventral horn in an SMS patient revealed significant reductions in small and medium-sized neurons (70%, 33%, 27% decrease).
• Larger neurons (>1500 µm²) were not reduced in density but showed central chromatolysis, and affected muscles displayed neurogenic atrophy.
• Spinal GAD immunoreactivity and Purkinje cell density remained largely unchanged, despite elevated serum anti-GAD antibodies.

Findings:

• A reduction in small spinal neurons was confirmed alongside elevated anti-GAD antibodies in the SMS patient.
• Preserved spinal GAD-like immunoreactivity and unchanged GAD-containing neurons outside the spinal cord challenge a purely autoimmune explanation.
• Qualitative changes in larger alpha-motor neurons, not density reduction, were observed.

Implications:

• The findings suggest that while anti-GAD antibodies may be present, the pathogenesis of Stiff-man syndrome likely involves mechanisms beyond simple autoimmune destruction of GAD-producing neurons.
• Further research is needed to explore diverse factors contributing to SMS, including potential non-autoimmune pathways.
• This study highlights the complexity of Stiff-man syndrome and calls for a broader understanding of its etiology.